An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]
Citrome L, Graham C, Simmons A, et al. Neuropsychiatr Dis Treat. 2021;17:2885–2904. The authors have advised there is an error in Figure 1C on page 2894. The key “OLZ/SAM” should read “Olanzapine + samidorphan 10 mg” and “Olanzapine&rdq...
Saved in:
Main Authors: | Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2f956761b90540fb83ae4e6a7146f4e3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
by: Citrome L, et al.
Published: (2021) -
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
by: Citrome L, et al.
Published: (2019) -
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
by: Sapunar Z,Jorge, et al.
Published: (2009) -
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
by: Ward K, et al.
Published: (2019) -
One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
by: Mohammed Zain Ulabedin Adhoni, et al.
Published: (2021)